Cargando…
Sildenafil for Primary Prevention of Anthracycline-Induced Cardiac Toxicity: A Phase I/II Randomized Clinical Trial, SILDAT-TAHA6 Trial
BACKGROUND: Previous animal studies have shown a protective effect of 5-phosphodiesterase inhibitors on cancer therapeutics-related cardiac dysfunction (CTRCD) of anthracyclines. AIM: The aim of this study was to evaluate the clinical effect of sildenafil on the primary prevention of CTRCD in human....
Autores principales: | Attar, Armin, Heydari, Masoumeh, Abtahi, Firoozeh, Rezvani, Alireza, Haghighat, Shirin, Vojdani, Reza, Ramzi, Mani, Dehghani, Mehdi, Karimi, Mojtaba, Kasaei, Mohammad, Khosropanah, Shahdad, Tabandeh, Mahmood |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977337/ https://www.ncbi.nlm.nih.gov/pubmed/35387238 http://dx.doi.org/10.1155/2022/5681510 |
Ejemplares similares
-
Obituary: Dr. Mohamed Taha Aljasser
por: Eldawlatly, Abdelazeem A.
Publicado: (2019) -
Single vs. double intracoronary injection of mesenchymal stromal cell after acute myocardial infarction: the study protocol from a randomized clinical trial: BOOSTER-TAHA7 trial
por: Attar, Armin, et al.
Publicado: (2022) -
Effect of once versus twice intracoronary injection of allogeneic-derived mesenchymal stromal cells after acute myocardial infarction: BOOSTER-TAHA7 randomized clinical trial
por: Attar, Armin, et al.
Publicado: (2023) -
Transplantation of mesenchymal stem cells for prevention of acute myocardial infarction induced heart failure: study protocol of a phase III randomized clinical trial (Prevent-TAHA8)
por: Attar, Armin, et al.
Publicado: (2022) -
Prof. Mohamed Taha Al-jasser (1928–2019)
por: Takrouri, Mohamad S. M.
Publicado: (2019)